- Cytochalasin E
-
Cytochalasin E[1] Identifiers CAS number 36011-19-5 PubChem 5458385 EC number 252-835-7 Jmol-3D images Image 1 - C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@]2(C(=O)N[C@H]4CC5=CC=CC=C5)OC(=O)O/C=C/[C@@](C1=O)(C)O)C)C
Properties Molecular formula C28H33NO7 Molar mass 495.56 g mol−1 Hazards EU classification T+ R-phrases R26/27/28 R63 S-phrases S28 S36/37 S45 Main hazards Toxic E (verify) (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)Infobox references Cytochalasin E, a member of the cytochalasin group, is an inhibitor of actin polymerization in blood platelets. It inhibits angiogenesis and tumor growth. Unlike cytochalasin A and cytochalasin B, it does not inhibit glucose transport.
Because of its antiangiogenic effect, cytochalasin E is a potential drug for age-related macular degeneration, a kind of blindness caused by an abnormal proliferation of blood vessels in the eye.[2]
References
External pages
Cytochalasin E from Fermentek
Categories:- Mycotoxins
- Actin inhibitors
- Carbonate esters
- Epoxides
- Biochemistry stubs
Wikimedia Foundation. 2010.